Trial Profile
Absolute oral bioavailability of almorexant, a dual orexin receptor antagonist, in healthy human subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Almorexant (Primary) ; Almorexant
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 24 May 2012 New trial record